Ernest Mario - Net Worth and Insider Trading

Ernest Mario Net Worth

The estimated net worth of Ernest Mario is at least $16 Million dollars as of 2024-11-09. Ernest Mario is the Director of Boston Scientific Corp and owns about 86,032 shares of Boston Scientific Corp (BSX) stock worth over $8 Million. Ernest Mario is the Director of Celgene Corp and owns about 60,237 shares of Celgene Corp (CELG) stock worth over $7 Million. Ernest Mario is also the Director of Kindred Biosciences Inc and owns about 99,583 shares of Kindred Biosciences Inc (KIN) stock worth over $921,143. Besides these, Ernest Mario also holds XenoPort Inc (XNPT) , Eyenovia Inc (EYEN) , Chimerix Inc (CMRX) , VIVUS Inc (VVUSQ) , Tonix Pharmaceuticals Holding Corp (TNXP) . Details can be seen in Ernest Mario's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ernest Mario has not made any transactions after 2020-03-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ernest Mario

Ernest Mario Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ernest Mario owns 11 companies in total, including Eyenovia Inc (EYEN) , Soleno Therapeutics Inc (SLNO) , and Kindred Biosciences Inc (KIN) among others .

Click here to see the complete history of Ernest Mario’s form 4 insider trades.

Insider Ownership Summary of Ernest Mario

Ticker	Comapny	Transaction Date	Type of Owner
EYEN	Eyenovia Inc	2020-09-11	director
SLNO	Soleno Therapeutics Inc	2015-08-11	director & 10 percent owner
KIN	Kindred Biosciences Inc	2020-01-17	director
		2019-11-19	director
		2018-06-25	director
		2018-05-18	director
		2015-11-16	director
		2015-05-19	director
		2013-05-29	director
		2007-07-18	director
		2019-11-19	director

Ernest Mario Latest Holdings Summary

Ernest Mario currently owns a total of 8 stocks. Among these stocks, Ernest Mario owns 86,032 shares of Boston Scientific Corp (BSX) as of November 16, 2015, with a value of $8 Million and a weighting of 47.73%. Ernest Mario owns 60,237 shares of Celgene Corp (CELG) as of February 12, 2019, with a value of $7 Million and a weighting of 40.99%. Ernest Mario also owns 99,583 shares of Kindred Biosciences Inc (KIN) as of March 15, 2016, with a value of $921,143 and a weighting of 5.79%. The other 5 stocks XenoPort Inc (XNPT) , Eyenovia Inc (EYEN) , Chimerix Inc (CMRX) , VIVUS Inc (VVUSQ) , Tonix Pharmaceuticals Holding Corp (TNXP) have a combined weighting of 5.48% among all his current holdings.

Latest Holdings of Ernest Mario

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BSX	Boston Scientific Corp	2015-11-16	86,032	88.25	7,592,324
CELG	Celgene Corp	2019-02-12	60,237	108.24	6,520,053
KIN	Kindred Biosciences Inc	2016-03-15	99,583	9.25	921,143
XNPT	XenoPort Inc	2014-05-23	83,750	7.07	592,113
EYEN	Eyenovia Inc	2020-03-24	327,239	0.49	160,053
CMRX	Chimerix Inc	2018-05-18	121,072	0.98	118,651
VVUSQ	VIVUS Inc	2013-05-29	8,113	0.12	952
TNXP	Tonix Pharmaceuticals Holding Corp	2018-06-25	0	0.14	0

Holding Weightings of Ernest Mario

Ernest Mario Form 4 Trading Tracker

According to the SEC Form 4 filings, Ernest Mario has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 125,000 shares on November 16, 2015, which brought Ernest Mario around $2 Million.

According to the SEC Form 4 filings, Ernest Mario has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the acquisition of 2,000 shares on February 12, 2019, which cost Ernest Mario around $179,980.

According to the SEC Form 4 filings, Ernest Mario has made a total of 0 transactions in Kindred Biosciences Inc (KIN) over the past 5 years. The most-recent trade in Kindred Biosciences Inc is the acquisition of 30,000 shares on March 15, 2016, which cost Ernest Mario around $106,500.

More details on Ernest Mario's insider transactions can be found in the Insider Trading History of Ernest Mario table.

Insider Trading History of Ernest Mario

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ernest Mario Trading Performance

GuruFocus tracks the stock performance after each of Ernest Mario's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ernest Mario is 3.22%. GuruFocus also compares Ernest Mario's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ernest Mario within 3 months outperforms 35 times out of 68 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ernest Mario's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ernest Mario

Average Return

Average return per transaction

Outperforming Transactions

35 out of 67 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	4.82
Relative Return to S&P 500(%)	4.47

Ernest Mario Ownership Network

Ownership Network List of Ernest Mario

No Data

Ownership Network Relation of Ernest Mario

Ernest Mario Owned Company Details

What does Eyenovia Inc do?

Who are the key executives at Eyenovia Inc?

Ernest Mario is the director of Eyenovia Inc. Other key executives at Eyenovia Inc include director & Chief Executive Officer Michael M Rowe , 10 percent owner Stuart M. Grant , and Chief Financial Officer John P Gandolfo .

Eyenovia Inc (EYEN) Insider Trades Summary

Over the past 18 months, Ernest Mario made no insider transaction in Eyenovia Inc (EYEN). Other recent insider transactions involving Eyenovia Inc (EYEN) include a net purchase of 1,839,115 shares made by Stuart M. Grant , a net purchase of 84,498 shares made by Michael M Rowe , and a net purchase of 14,820 shares made by Ellen R Strahlman .

In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc (EYEN) in total and bought 77,071 shares, with a net purchase of 77,071 shares. During the past 18 months, 0 shares of Eyenovia Inc (EYEN) were sold and 1,949,933 shares were bought by its insiders, resulting in a net purchase of 1,949,933 shares.

Eyenovia Inc (EYEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eyenovia Inc Insider Transactions

No Available Data

What does Soleno Therapeutics Inc do?

Who are the key executives at Soleno Therapeutics Inc?

Ernest Mario is the director & 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include Chief Financial Officer James H Mackaness , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .

Soleno Therapeutics Inc (SLNO) Insider Trades Summary

Over the past 18 months, Ernest Mario made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 479,373 shares made by Bhatnagar Anish , a net sale of 79,014 shares made by Kristen Yen , and a net sale of 47,490 shares made by Patricia C Hirano .

In summary, during the past 3 months, insiders sold 1,210,871 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,210,871 shares. During the past 18 months, 2,825,824 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 1,615,737 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soleno Therapeutics Inc Insider Transactions

No Available Data

What does Kindred Biosciences Inc do?

Who are the key executives at Kindred Biosciences Inc?

Ernest Mario is the director of Kindred Biosciences Inc. Other key executives at Kindred Biosciences Inc include director & Chief Executive Officer Richard Chin , 10 percent owner Park West Asset Management Llc , and Chief Financial Officer Wendy Wee .

Kindred Biosciences Inc (KIN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kindred Biosciences Inc (KIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kindred Biosciences Inc (KIN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kindred Biosciences Inc (KIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kindred Biosciences Inc Insider Transactions

No Available Data

What does Amplitude Healthcare Acquisition Corp do?

Who are the key executives at Amplitude Healthcare Acquisition Corp?

Ernest Mario is the director of Amplitude Healthcare Acquisition Corp. Other key executives at Amplitude Healthcare Acquisition Corp include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and President Vishal Kapoor .

Amplitude Healthcare Acquisition Corp (AMHCU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Amplitude Healthcare Acquisition Corp (AMHCU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amplitude Healthcare Acquisition Corp (AMHCU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Amplitude Healthcare Acquisition Corp (AMHCU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amplitude Healthcare Acquisition Corp Insider Transactions

No Available Data

What does Tonix Pharmaceuticals Holding Corp do?

Who are the key executives at Tonix Pharmaceuticals Holding Corp?

Ernest Mario is the director of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include director & 10 percent owner & Chief Executive Officer Seth Lederman , Chief Medical Officer Gregory M Sullivan , and Chief Administrative Officer Jessica Edgar Morris .

Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tonix Pharmaceuticals Holding Corp Insider Transactions

No Available Data

What does Chimerix Inc do?

Who are the key executives at Chimerix Inc?

Ernest Mario is the director of Chimerix Inc. Other key executives at Chimerix Inc include Chief Business Officer Michael T. Andriole , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .

Chimerix Inc (CMRX) Insider Trades Summary

Over the past 18 months, Ernest Mario made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 40,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 3,029 shares made by Michael T. Andriole .

In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 145,000 shares were bought by its insiders, resulting in a net purchase of 133,761 shares.

Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chimerix Inc Insider Transactions

No Available Data

What does Boston Scientific Corp do?

Who are the key executives at Boston Scientific Corp?

Ernest Mario is the director of Boston Scientific Corp. Other key executives at Boston Scientific Corp include President Michael F Mahoney , SVP & Human Resources Wendy Carruthers , and SVP & President & Endovascular Joseph Michael Fitzgerald .

Boston Scientific Corp (BSX) Insider Trades Summary

Over the past 18 months, Ernest Mario made no insider transaction in Boston Scientific Corp (BSX). Other recent insider transactions involving Boston Scientific Corp (BSX) include a net sale of 156,216 shares made by Wendy Carruthers , a net sale of 144,352 shares made by Jeffrey B. Mirviss , and a net sale of 828,398 shares made by Michael F Mahoney .

In summary, during the past 3 months, insiders sold 669,952 shares of Boston Scientific Corp (BSX) in total and bought 0 shares, with a net sale of 669,952 shares. During the past 18 months, 1,757,271 shares of Boston Scientific Corp (BSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,757,271 shares.

Boston Scientific Corp (BSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Boston Scientific Corp Insider Transactions

No Available Data

What does XenoPort Inc do?

Who are the key executives at XenoPort Inc?

Ernest Mario is the director of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .

XenoPort Inc (XNPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

XenoPort Inc Insider Transactions

No Available Data

What does VIVUS Inc do?

Who are the key executives at VIVUS Inc?

Ernest Mario is the director of VIVUS Inc. Other key executives at VIVUS Inc include director & Chief Executive Officer John P. Amos , Chief Medical Officer Santosh T Varghese , and Chief Financial Officer & CAO Mark K Oki .

VIVUS Inc (VVUSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of VIVUS Inc (VVUSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIVUS Inc (VVUSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

VIVUS Inc (VVUSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

VIVUS Inc Insider Transactions

No Available Data

What does Alexza Pharmaceuticals Inc do?

Who are the key executives at Alexza Pharmaceuticals Inc?

Ernest Mario is the director of Alexza Pharmaceuticals Inc. Other key executives at Alexza Pharmaceuticals Inc include director & President & CEO Thomas Braxton King , Former SVP & CFO & Secretary Mark K Oki , and EVP & Operations & COO Robert A Lippe .

Alexza Pharmaceuticals Inc (ALXA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexza Pharmaceuticals Inc (ALXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexza Pharmaceuticals Inc (ALXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexza Pharmaceuticals Inc (ALXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alexza Pharmaceuticals Inc Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Ernest Mario is the director of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Ernest Mario made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net sale of 11,700 shares made by Jeetinder Singh Mahal , a net purchase of 50,000 shares made by Thomas G Wiggans , and a net purchase of 350,000 shares made by Velan Capital Master Fund Lp .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 4,397 shares of Jasper Therapeutics Inc (JSPR) were sold and 545,000 shares were bought by its insiders, resulting in a net purchase of 540,604 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

Ernest Mario Mailing Address

Above is the net worth, insider trading, and ownership report for Ernest Mario. You might contact Ernest Mario via mailing address: 20 Fairmount Avenue, P.o. Box 445, Chatham Nj 07928.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.